V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori
Authors
Keywords
Bismuth, Clarithromycin, Helicobacter pylori, Proton pump inhibitor, Levofloxacin, Metronidazole, Omeprazole, Tetracycline
Journal
Gastroenterologia y Hepatologia
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-10-09
DOI
10.1016/j.gastrohep.2021.07.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020
- (2021) Hye-Kyung Jung et al. Gut and Liver
- Room for Improvement in the Treatment of Helicobacter pylori Infection
- (2021) Olga P. Nyssen et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Adverse Event Profile During the Treatment of Helicobacter pylori
- (2021) Olga P. Nyssen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis
- (2021) Theodore Rokkas et al. GASTROENTEROLOGY
- Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community
- (2021) Francis Megraud et al. GUT
- Delay in Retreatment of Helicobacter pylori Infection Increases Risk of Upper Gastrointestinal Bleeding
- (2020) Chuan-Guo Guo et al. Clinical Gastroenterology and Hepatology
- Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy
- (2020) Javier Alcedo et al. Gastroenterologia y Hepatologia
- Helicobacter pylori “Test-and-Treat” strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative
- (2020) Ariel Beresniak et al. HELICOBACTER
- Non‐bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real‐life study
- (2020) Marco Romano et al. HELICOBACTER
- PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis
- (2020) Cai‐Ping Gao et al. HELICOBACTER
- Helicobacter pylori first‐line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp‐EuReg)
- (2020) Olga P. Nyssen et al. HELICOBACTER
- Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection
- (2020) Ilaria M. Saracino et al. European Journal of Internal Medicine
- AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders
- (2020) Grace L. Su et al. GASTROENTEROLOGY
- Efficacy and safety of a new rifabutin‐based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single‐arm study
- (2020) Yoshihiro Hirata et al. HELICOBACTER
- Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg)
- (2020) Olga P. Nyssen et al. HELICOBACTER
- European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
- (2020) Olga P Nyssen et al. GUT
- Rifabutin for the Treatment of Helicobacter pylori Infection: A Review
- (2020) Javier P. Gisbert Pathogens
- Efficacy and safety of bismuth-containing quadruple treatment and concomitant treatment for first-line Helicobacter pylori eradication: A systematic review and meta-analysis
- (2020) Biao Guo et al. MICROBIAL PATHOGENESIS
- European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice
- (2020) Olga P. Nyssen et al. United European Gastroenterology Journal
- Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori
- (2019) Olga P. Nyssen et al. HELICOBACTER
- Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor
- (2019) Maria Pina Dore et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients
- (2019) Adrian G. McNicholl et al. Clinical Gastroenterology and Hepatology
- Alertas sobre la seguridad de las quinolonas: ¿debemos modificar su prescripción en el tratamiento de la infección por Helicobacter pylori
- (2019) Adrian G. McNicholl et al. Gastroenterologia y Hepatologia
- Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions
- (2019) Adrian G. McNicholl et al. HELICOBACTER
- Efficacy and safety of probiotics in eradicating Helicobacter pylori
- (2019) Xiaoguang Shi et al. MEDICINE
- Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Clinical Trials
- (2019) Qiu-Ju Lyu et al. Biomed Research International
- Helicobacter pylori pathogenicity and primary antimicrobial resistance in Northern Spain
- (2019) María Fernández‐Reyes et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study
- (2019) Ana Morilla Morilla et al. Gastroenterologia y Hepatologia
- Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)
- (2019) Adrian G. McNicholl et al. HELICOBACTER
- Penicillin Allergy
- (2019) Mariana Castells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in World Health Organization regions
- (2018) Alessia Savoldi et al. GASTROENTEROLOGY
- Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori
- (2018) Neus Muñoz et al. HELICOBACTER
- Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori
- (2018) Min Li et al. HELICOBACTER
- Efficacy of two different dosages of levofloxacin in curing Helicobacter pylori infection: A Prospective, Single-Center, randomized clinical trial
- (2018) Huo-Ye Gan et al. Scientific Reports
- Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial
- (2018) Adrian G. McNicholl et al. HELICOBACTER
- Systematic review with network meta-analysis: Effectiveness of therapies for second-line Helicobacter pylori eradication
- (2018) Yee Hui Yeo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial
- (2018) Fernando Macías-García et al. HELICOBACTER
- Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies
- (2018) Angel Cosme et al. HELICOBACTER
- Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis
- (2017) Jue-Rong Feng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial
- (2017) Mercedes Ramas et al. Gastroenterologia y Hepatologia
- Review: A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?
- (2017) Shou Quan Dong et al. HELICOBACTER
- High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: A prevalence cross-sectional study in Spain
- (2017) Fernando Macías-García et al. HELICOBACTER
- Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera® ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study
- (2017) Enrique Rodríguez de Santiago et al. HELICOBACTER
- Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
- (2017) Evrim Kahramanoğlu Aksoy et al. MEDICAL PRINCIPLES AND PRACTICE
- A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients
- (2017) Blas José Gómez Rodríguez et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Probiotics in Helicobacter pylori eradication therapy: Systematic review and network meta-analysis
- (2017) Fan Wang et al. Clinics and Research in Hepatology and Gastroenterology
- Probiotics in 14-day triple therapy for Asian pediatric patients with Helicobacter pylori infection: a network meta-analysis
- (2017) Juanjuan Wen et al. Oncotarget
- Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients
- (2017) Hideki Mori et al. United European Gastroenterology Journal
- Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy
- (2017) Rong Zhu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
- (2016) Zhiqiang Song et al. DIGESTIVE AND LIVER DISEASE
- Triple terapia 10 días con esomeprazol 40 mg/12 h vs. cuádruple concomitante sin bismuto como tratamiento de primera línea de la infección por Helicobacter pylori
- (2016) Ana Campillo et al. Gastroenterologia y Hepatologia
- IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori
- (2016) Javier P. Gisbert et al. Gastroenterologia y Hepatologia
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
- (2016) Carlo A. Fallone et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies
- (2016) Antonio Francesco Ciccaglione et al. HELICOBACTER
- Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
- (2016) Jyh-Ming Liou et al. LANCET
- Comparación de cuádruple terapia concomitante sin bismuto con triple terapia clásica como primera línea de tratamiento para la erradicación del Helicobacter pylori
- (2016) Ana Campillo et al. MEDICINA CLINICA
- Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication
- (2016) Han Chen et al. MEDICINE
- Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
- (2016) Muhan LÜ et al. PLoS One
- Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis
- (2016) Chao Lu et al. Scientific Reports
- Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events
- (2016) Lynne V McFarland et al. United European Gastroenterology Journal
- Rescue Therapy Using a Rifabutin-Based Regimen is Effective for Cure ofHelicobacter pyloriInfection
- (2016) Sander Veldhuyzen van Zanten et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia
- (2016) Cemal Nuri ERCIN et al. Turkish Journal of Gastroenterology
- Canadian Association of Gastroenterology Policy on the Application for, and Implementation of, Clinical Practice Guidelines
- (2016) Harminder Singh et al. Canadian Journal of Gastroenterology and Hepatology
- Helicobacter pylorisecond-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second line regimen in the presence of levofloxacin resistance
- (2015) D. Y. Graham et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study
- (2015) J. Molina-Infante et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain
- (2015) José María Navarro-Jarabo et al. DIGESTION
- How to Effectively Use Bismuth Quadruple Therapy
- (2015) David Y. Graham et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-lineHelicobacter pyloritherapy
- (2015) Wei Zhang et al. GUT
- Kyoto global consensus report onHelicobacter pylorigastritis
- (2015) Kentaro Sugano et al. GUT
- Helicobacter pylori Eradication within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients
- (2015) Shen Shong Chang et al. Gut and Liver
- Sequential Therapy forHelicobacter pyloriInfection in Treatment-naïve Children
- (2015) Andrea Schwarzer et al. HELICOBACTER
- Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication ofHelicobacter pyloriin a Region with High Rate of Clarithromycin Resistance
- (2015) Angel Cosme et al. HELICOBACTER
- Tailored versus Triple plus Bismuth or Concomitant Therapy as InitialHelicobacter pyloriTreatment: A Randomized Trial
- (2015) Liya Zhou et al. HELICOBACTER
- Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment forHelicobacter pyloriinfection
- (2015) Sheila López-Góngora et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- First-line eradication rates comparing two shortened non-bismuth quadruple regimens againstHelicobacter pylori: an open-label, randomized, multicentre clinical trial
- (2015) Antonio Cuadrado-Lavín et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Concomitant and hybrid therapy forHelicobacter pyloriinfection: A randomized clinical trial
- (2015) Jun Heo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Probiotics for Standard Triple Helicobacter pylori Eradication
- (2015) Goran Hauser et al. MEDICINE
- Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial
- (2015) Zhijun Cao et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Probiotics inHelicobacter pylorieradication therapy: A systematic review and meta-analysis
- (2015) Min-Min Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Optimal initiation ofHelicobacter pylorieradication in patients with peptic ulcer bleeding
- (2015) Hyuk Yoon WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis
- (2015) ZHIFA LV et al. Experimental and Therapeutic Medicine
- Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
- (2014) Javier P. Gisbert et al. DIGESTIVE DISEASES AND SCIENCES
- Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions
- (2014) Maider Martos et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Helicobacter pyloriInfection in Children. Antimicrobial Resistance and Treatment Response
- (2014) Milagrosa Montes et al. HELICOBACTER
- Eradication of H. pylori Infection in Patients Allergic to Penicillin Using Triple Therapy with a PPI, Metronidazole and Sitafloxacin
- (2014) Takahisa Furuta et al. INTERNAL MEDICINE
- Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study
- (2014) V. De Francesco et al. JOURNAL OF MEDICAL MICROBIOLOGY
- The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis
- (2014) Yini Dang et al. PLoS One
- Lactobacillus -containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis
- (2014) Xi Zheng et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Probiotics for Helicobacter pylori eradication therapy: not ready for prime time
- (2014) Javier Molina-Infante et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
- (2014) Javier Molina-Infante WORLD JOURNAL OF GASTROENTEROLOGY
- Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study
- (2013) Tomás Navarro-Rodriguez et al. BMC GASTROENTEROLOGY
- Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
- (2013) Xiao Liang et al. Clinical Gastroenterology and Hepatology
- Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
- (2013) David Y. Graham et al. Clinical Gastroenterology and Hepatology
- Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment ofHelicobacter pyloriInfection
- (2013) Marino Venerito et al. DIGESTION
- Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
- (2013) J. P. Gisbert et al. DIGESTIVE DISEASES AND SCIENCES
- Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children
- (2013) Shan Li et al. EUROPEAN JOURNAL OF PEDIATRICS
- A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
- (2013) Alicia C Marin et al. EXPERT OPINION ON PHARMACOTHERAPY
- III Conferencia Española de Consenso sobre la infección por Helicobacter pylori
- (2013) Javier P. Gisbert et al. Gastroenterologia y Hepatologia
- Actualización de la eficacia de la terapia triple para la infección por Helicobacter pylori y de la resistencia a claritromicina en España (2007-2012)
- (2013) Javier Molina-Infante et al. Gastroenterologia y Hepatologia
- Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
- (2013) Javier Molina–Infante et al. GASTROENTEROLOGY
- Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment forHelicobacter pyloriin Chinese patients: an open label, randomised, crossover trial
- (2013) Kevin S H Liu et al. GUT
- Randomised clinical trial comparing sequential and concomitant therapies forHelicobacter pylorieradication in routine clinical practice
- (2013) Adrian G McNicholl et al. GUT
- The Effects of Multistrain Probiotic Compound on Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A Randomized Placebo-Controlled Triple-Blind Study
- (2013) Ahmad Shavakhi et al. HELICOBACTER
- Clinical Outcomes of Two-Week Sequential and Concomitant Therapies forHelicobacter pyloriEradication: A Randomized Pilot Study
- (2013) Ji Hyun Lim et al. HELICOBACTER
- Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
- (2013) Jingxian Liao et al. HELICOBACTER
- Clinical Evaluation of a Ten-Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication ofHelicobacter pyloriin a High Clarithromycin Resistance Area
- (2013) Sotirios D. Georgopoulos et al. HELICOBACTER
- Meta-analysis: Is sequential therapy superior to standard triple therapy forHelicobacter pyloriinfection in Asian adults?
- (2013) Hyuk Yoon et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Concomitant, sequential, and hybrid therapy for H. pylori eradication: A pilot study
- (2013) Angelo Zullo et al. Clinics and Research in Hepatology and Gastroenterology
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
- (2013) L. Gatta et al. BMJ-British Medical Journal
- Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection
- (2012) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures
- (2012) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Helicobacter pylorieradication in Western Australia using novel quadruple therapy combinations
- (2012) C. Y. Tay et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-Term Follow-Up of 1,000 Patients Cured of Helicobacter pylori Infection Following an Episode of Peptic Ulcer Bleeding
- (2012) J P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate
- (2012) Marco Manfredi et al. HELICOBACTER
- The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study
- (2012) Seng-Kee Chuah et al. HELICOBACTER
- Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains
- (2012) Javier Molina-Infante et al. HELICOBACTER
- Pilot Studies to Identify the Optimum Duration of Concomitant Helicobacter pylori Eradication Therapy in Thailand
- (2012) Chutima Kongchayanun et al. HELICOBACTER
- Strategies for peptic ulcer healing after 1 week proton pump inhibitor-based triple Helicobacter pylori eradication therapy in Japanese patients: differences of gastric ulcers and duodenal ulcers
- (2012) Toshihisa Takeuchi et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
- (2012) Javier P. Gisbert et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy
- (2012) Zhen-Hua Wang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Helicobacter pylorieradication: Sequential therapy andLactobacillus reuterisupplementation
- (2012) Cesare Efrati WORLD JOURNAL OF GASTROENTEROLOGY
- Levofloxacin/amoxicillin-based schemesvsquadruple therapy forHelicobacter pylorieradication in second-line
- (2012) Simona Di Caro WORLD JOURNAL OF GASTROENTEROLOGY
- The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy
- (2012) Francis Mégraud Therapeutic Advances in Gastroenterology
- Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Tratamientos de rescate ante el fracaso erradicador de Helicobacter pylori
- (2011) Javier P. Gisbert Gastroenterologia y Hepatologia
- A New Modified Concomitant Therapy for Helicobacter pylori Eradication in Turkey
- (2011) Ahmet Burak Toros et al. HELICOBACTER
- Twice-a-Day Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Trial of 10 and 14 Days
- (2011) Maria Pina Dore et al. HELICOBACTER
- Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain
- (2011) A. Cuadrado-Lavin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
- (2011) Peter Malfertheiner et al. LANCET
- Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment
- (2010) H. Szajewska et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice
- (2010) Stefano Pontone et al. DIGESTIVE AND LIVER DISEASE
- Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
- (2010) Takahisa Furuta et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- One-Week Once-Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin
- (2010) Stephan Miehlke et al. HELICOBACTER
- Sequential Therapy for Helicobacter pylori Eradication
- (2010) Javier P. Gisbert et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Bismuth improves PPI-based triple therapy for H. pylori eradication
- (2010) Peter Malfertheiner Nature Reviews Gastroenterology & Hepatology
- Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
- (2010) Yuqin Li et al. WIENER KLINISCHE WOCHENSCHRIFT
- Standard triple, bismuth pectin quadruple and sequential therapies forHelicobacter pylorieradication
- (2010) Xiao-Zhong Gao WORLD JOURNAL OF GASTROENTEROLOGY
- Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability
- (2009) Jay Luther et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin
- (2009) J.P. Gisbert et al. DIGESTIVE AND LIVER DISEASE
- Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients
- (2009) Zsolt Tulassay et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Cumulative H. pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen
- (2008) Theodore Rokkas et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
- (2008) S. Di Caro et al. DIGESTIVE AND LIVER DISEASE
- Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures
- (2008) P. I. Hsu et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials
- (2008) Aarti Sachdeva et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- ¿Cómo localizar, elaborar, evaluar y utilizar guías de práctica clínica?
- (2008) Javier P. Gisbert et al. Gastroenterologia y Hepatologia
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More